Medical News

RSS

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

Emergent BioSolutions Inc. announced today that its Investigational New Drug (IND) application, to commence a Phase I clinical trial for its anthrax monoclonal antibody therapeutic, has cleared U.S. Food and Drug Administration (FDA) review. The Phase I study will evaluate the safety and pharmacokinetics of the company's fully human monoclonal antibody being developed as a parenteral post-exposure therapy for individuals who have symptoms of anthrax disease. In pre-clinical therapeutic studies, Emergent's monoclonal antibody was found to be effective.

17 May 2010

Neovasc first-quarter revenues increase nearly 300% to $1.06 million

Neovasc Inc., today announced financial results for the three months ended March 31, 2009.

17 May 2010

NanoViricides signs Research Agreement with UCSF for testing anti-HIV drug candidates

NanoViricides, Inc., announced that it has signed a Research Agreement with the University of California, San Francisco for testing of its anti-HIV drug candidates. Cheryl Stoddart, PhD, Assistant Professor in the UCSF Division of Experimental Medicine, will be the Principal Investigator.

17 May 2010

Aeterna Zentaris' AEZS-108 receives orphan medicinal product designation for ovarian cancer in Europe

Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for its compound AEZS-108 for the treatment of ovarian cancer. AEZS-108, the Company's doxorubicin targeted conjugate compound, is currently in a Phase 2 trial in advanced ovarian and advanced endometrial cancer in Europe.

17 May 2010

LLS's School & Youth Programs raise $1M to help fight against childhood cancer

Participants in The Leukemia & Lymphoma Society's Greater Los Angeles Chapter School & Youth(SM) Programs raised an unprecedented $1 million this spring, in a campaign that gives kids a chance to help in the fight against blood cancers.

17 May 2010

Tiens Biotech first-quarter revenues decrease to $11.4 million

Tiens Biotech Group (USA), Inc.,, today announced financial results for the first quarter ended March 31, 2010.

17 May 2010

Freescale Semiconductor receives ZigBee Certification for wireless health and wellness solutions

Freescale Semiconductor today announced it has received ZigBee Certified product status for its ZigBee Health Care wireless health and wellness processing platforms. The ZigBee Certified products status is awarded to products that have been tested and met criteria for interoperability that enable wireless devices to securely and reliably monitor and manage noncritical, low-acuity health care services.

17 May 2010

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

Celldex Therapeutics, Inc. today announced that the first patient has been screened in a randomized Phase 2 study of the Company's novel, first-in-class antibody-based vaccine candidate from its Precision Targeted Immunotherapy (PTI) platform. This study will evaluate the CDX-1307 regimen in both neoadjuvant and adjuvant settings in patients with newly diagnosed muscle-invasive bladder cancers that express hCG-beta.

17 May 2010

Biostar Pharmaceuticals first-quarter 2010 revenues increase 66.0% to $12.4 million

Biostar Pharmaceuticals, Inc., a Xianyang- based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced financial results of the first quarter ended March 31, 2010.

17 May 2010

AngioDynamics launches Morpheus Smart PICC Triple Lumen CT PICC

AngioDynamics announced today the launch of the first member of its new generation of peripherally inserted central catheters (PICCs) for procedures involving the use of contrast media in computed tomography (CT) - the Morpheus Smart PICC Triple Lumen CT PICC.

17 May 2010

First Edition: May 17, 2010

Today's headlines highlight stories about efforts to advance the implementation of federal health reforms as well as the sweeping measure's political impact in primary races across the country.

17 May 2010

Jiangbo Pharmaceuticals third-quarter revenue decreases 0.6% to $25.6 million

Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for the third quarter fiscal year 2010 ended March 31, 2010.

17 May 2010

MicroStockProfit.com: BSMD's total worldwide revenues for first-quarter 2010 decline 2%

MicroStockProfit.com announces an investment report featuring BioSphere Medical Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

17 May 2010

Titan Pharmaceuticals reports total revenues of $2.4M for first-quarter 2010

Titan Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010.

17 May 2010

China Biologic first-quarter revenues up 28.1% to $27.1 million

China Biologic Products, Inc., one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. and its equity investment in Xi'an Huitian Blood Products Co., Ltd., today reported financial results for its first quarter ended March 31, 2010.

17 May 2010

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

Tranzyme Pharma today announced that Philippa Charlton, MD, Tranzyme's Medical Director, and her colleagues G. Bochicchio, J.C. Pezullo, G. Kosutic, and A. Senagore, will present a poster entitled "The Prokinetic Agent TZP-101 (a Ghrelin Agonist) Accelerates GI Recovery in Partial Colectomy Patients Independently of Total Opioid Use and Type of Surgery" at the upcoming 2010 Annual Scientific Meeting of the American Society of Colon and Rectal Surgeons (ASCRS; Minneapolis, May 15-19).

17 May 2010

Quality Systems wins Growth Award in public company category from ACG OC

Quality Systems, Inc. announced today that it has won the Growth Award in the public company category from The Association for Corporate Growth Orange County Chapter.

17 May 2010

ElexoPharm GmbH, Merck announce collaboration and exclusive worldwide license agreement

ElexoPharm GmbH announced today a collaboration and exclusive worldwide license agreement with Merck & Co., Inc. Whitehouse Station, New Jersey USA (also known as MSD outside of the US and Canada) through an affiliate to develop and commercialize novel candidates targeting aldosterone synthase for the potential treatment of cardiovascular disease.

17 May 2010

Berman Institute experts available for comment on direct-to-consumer marketing of genetic test kits

Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.

17 May 2010

Call for papers, panels and posters for 2010 Pacific Rim Summit now open

The Biotechnology Industry Organization invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers, and posters for the 2010 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 11-14, 2010 in Honolulu.

17 May 2010

Medical News

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

Neovasc first-quarter revenues increase nearly 300% to $1.06 million

NanoViricides signs Research Agreement with UCSF for testing anti-HIV drug candidates

Aeterna Zentaris' AEZS-108 receives orphan medicinal product designation for ovarian cancer in Europe

LLS's School & Youth Programs raise $1M to help fight against childhood cancer

Tiens Biotech first-quarter revenues decrease to $11.4 million

Freescale Semiconductor receives ZigBee Certification for wireless health and wellness solutions

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

Biostar Pharmaceuticals first-quarter 2010 revenues increase 66.0% to $12.4 million

AngioDynamics launches Morpheus Smart PICC Triple Lumen CT PICC

First Edition: May 17, 2010

Jiangbo Pharmaceuticals third-quarter revenue decreases 0.6% to $25.6 million

MicroStockProfit.com: BSMD's total worldwide revenues for first-quarter 2010 decline 2%

Titan Pharmaceuticals reports total revenues of $2.4M for first-quarter 2010

China Biologic first-quarter revenues up 28.1% to $27.1 million

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

Quality Systems wins Growth Award in public company category from ACG OC

ElexoPharm GmbH, Merck announce collaboration and exclusive worldwide license agreement

Berman Institute experts available for comment on direct-to-consumer marketing of genetic test kits

Call for papers, panels and posters for 2010 Pacific Rim Summit now open

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News